19 results match your criteria: "Mayo Clinic Children's Research Center[Affiliation]"

From the Editor-in-Chief's Desk: Gratitude for Mentors and Colleagues.

J Child Adolesc Psychopharmacol

December 2024

Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, MN, USA.

View Article and Find Full Text PDF

From the Editor-in-Chief's Desk: Are Omega-3 Fatty Acid Supplements an Effective, Safe, and Scalable Treatment for Depression in Children and Adolescents?

J Child Adolesc Psychopharmacol

September 2024

Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article and Find Full Text PDF

From the Editor-in-Chief's Desk.

J Child Adolesc Psychopharmacol

August 2024

Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, MN, USA.

View Article and Find Full Text PDF

From the Editor-in-Chief's Desk: Advancing Evidence-Based Treatments for Disruptive Mood Dysregulation Disorder.

J Child Adolesc Psychopharmacol

June 2024

Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.

View Article and Find Full Text PDF

From the Editor-in-Chief's Desk: Precision Classification and Treatment of Early Life Mood Disorders for Improved Outcomes.

J Child Adolesc Psychopharmacol

May 2024

Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.

View Article and Find Full Text PDF

From the Editor-in-Chief's Desk: Advances in Patient-Centered Treatment for Attention-Deficit/Hyperactivity Disorder.

J Child Adolesc Psychopharmacol

April 2024

Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.

View Article and Find Full Text PDF

From the Editor-in-Chief's Desk: Reflecting on Our Past and Future.

J Child Adolesc Psychopharmacol

March 2024

Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.

View Article and Find Full Text PDF

A retrospective, naturalistic study of deep brain stimulation and vagal nerve stimulation in young patients.

Brain Behav

March 2024

Department of Psychiatry and Psychology, Mayo Clinic Children's Research Center, and Mayo Clinic Depression Center, Mayo Clinic, Rochester, Minnesota, USA.

Introduction: Invasive neuromodulation interventions such as deep brain stimulation (DBS) and vagal nerve stimulation (VNS) are important treatments for movement disorders and epilepsy, but literature focused on young patients treated with DBS and VNS is limited. This retrospective study aimed to examine naturalistic outcomes of VNS and DBS treatment of epilepsy and dystonia in children, adolescents, and young adults.

Methods: We retrospectively assessed patient demographic and outcome data that were obtained from electronic health records.

View Article and Find Full Text PDF

Understanding the Developmental Lines of Psychosis Spectrum Symptoms: Efforts and Early Insights From the Toronto Adolescent and Youth Cohort Study.

Biol Psychiatry Cogn Neurosci Neuroimaging

March 2024

Ervin A. and Margaret C. Mueller Mayo Clinic Children's Research Center, Departments of Psychiatry, Psychology, Pediatrics and Pharmacology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article and Find Full Text PDF

From the Editor's Desk: Progress and Challenges for Psychiatric Phenotypes in Youth.

J Child Adolesc Psychopharmacol

December 2023

Department of Psychiatry, Pharmacology, and Pediatrics, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.

View Article and Find Full Text PDF

From the Editors Desk.

J Child Adolesc Psychopharmacol

November 2023

Professor of Psychiatry, Pharmacology, and Pediatrics, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.

View Article and Find Full Text PDF

Parents frequently purchase and inquire about smartwatch devices to monitor child behaviors and functioning. This pilot study examined the feasibility and accuracy of using smartwatch monitoring for the prediction of disruptive behaviors. The study enrolled children ( = 10) aged 7-10 years hospitalized for the treatment of disruptive behaviors.

View Article and Find Full Text PDF

Defining the Architecture of the Core Machinery for the Assembly of Fe-S Clusters in Human Mitochondria.

Methods Enzymol

May 2018

Mayo Clinic, Rochester, MN, United States; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, United States; Mayo Clinic Children's Research Center, Rochester, MN, United States. Electronic address:

Although Fe-S clusters may assemble spontaneously from elemental iron and sulfur in protein-free systems, the potential toxicity of free Fe, Fe, and S ions in aerobic environments underscores the requirement for specialized proteins to oversee the safe assembly of Fe-S clusters in living cells. Prokaryotes first developed multiprotein systems for Fe-S cluster assembly, from which mitochondria later derived their own system and became the main Fe-S cluster suppliers for eukaryotic cells. Early studies in yeast and human mitochondria indicated that Fe-S cluster assembly in eukaryotes is centered around highly conserved Fe-S proteins (human ISCU) that serve as scaffolds upon which new Fe-S clusters are assembled from (i) elemental sulfur, provided by a pyridoxal phosphate-dependent cysteine desulfurase (human NFS1) and its stabilizing-binding partner (human ISD11), and (ii) elemental iron, provided by an iron-binding protein of the frataxin family (human FXN).

View Article and Find Full Text PDF

Fe-S clusters, essential cofactors needed for the activity of many different enzymes, are assembled by conserved protein machineries inside bacteria and mitochondria. As the architecture of the human machinery remains undefined, we co-expressed in Escherichia coli the following four proteins involved in the initial step of Fe-S cluster synthesis: FXN (iron donor); [NFS1]·[ISD11] (sulfur donor); and ISCU (scaffold upon which new clusters are assembled). We purified a stable, active complex consisting of all four proteins with 1:1:1:1 stoichiometry.

View Article and Find Full Text PDF

The biosynthesis of Fe-S clusters is a vital process involving the delivery of elemental iron and sulfur to scaffold proteins via molecular interactions that are still poorly defined. We reconstituted a stable, functional complex consisting of the iron donor, Yfh1 (yeast frataxin homologue 1), and the Fe-S cluster scaffold, Isu1, with 1:1 stoichiometry, [Yfh1]24·[Isu1]24 Using negative staining transmission EM and single particle analysis, we obtained a three-dimensional reconstruction of this complex at a resolution of ∼17 Å. In addition, via chemical cross-linking, limited proteolysis, and mass spectrometry, we identified protein-protein interaction surfaces within the complex.

View Article and Find Full Text PDF